adjuvant
121Specol — is a water in oil adjuvant composed of defined and purified light mineral oil (Stills. 2005). It has been suggested as an alternative to Freund s adjuvant for hyperactivation of the immune response in rabbits (Leenaars et al. 1994). Specol can be …
122Titermax — is a mixture of compounds used in antibody generation and vaccination to stimulate the immune system to recognise an antigen given together with the mixture. Titermax is a recently developed immune adjuvant.It is a water in oil emulsion and… …
123Edrecolomab — (MAb17 1A, Panorex®) is a chimeric mouse/human monoclonal antibody to the cell surface glycoprotein 17 1A, which is expressed on epithelial tissues and on various carcinomas.Preliminary studies had shown promise of a possible use in patients with …
124Dr Myko San - Health from Mushrooms — Dr Myko San – Health from Mushrooms (Croatian: Dr Myko San – Zdravlje iz gljiva) is a Croatian private company, based in Zagreb, producing and selling medicinal mushroom preparations. Dr Ivan Jakopović (IPA2|jʌˈkoːpoʋiʨ) and Marija Jakopović… …
125Pain ladder — The pain ladder is a term originally coined by the World Health Organisation (WHO) to describe a method of controlling pain [ [http://www.who.int/cancer/palliative/painladder/en/ WHO | WHO s pain ladder ] ] . It was originally described for the… …
126HspE7 — is an investigational therapeutic vaccine candidate being developed by Nventa Biopharmaceuticals for the treatment of precancerous and cancerous lesions caused by the human papillomavirus (HPV). HspE7 uses recombinant DNA technology to covalently …
127Global Vaccines — [http://www.globalvaccines.org Global Vaccines, Inc] is a mission driven non profit company applying state of the art science and innovative business strategies to design and develop affordable vaccines for people in poor countries.… …
128Accès de grippe porcine H1N1 de 2009 — Grippe A (H1N1) de 2009 La grippe A (H1N1) de 2009 est une maladie respiratoire aiguë contagieuse provoquée par un virus de la grippe A de sous type H1N1. Ce virus est réapparu en 2009 sous une nouvelle forme génétique transmissible d’homme à… …
